Journal of Anesthesia

, Volume 26, Issue 2, pp 219–224 | Cite as

Retrospective evaluation of intravenous fentanyl patient-controlled analgesia during labor

  • Yuki Hosokawa
  • Hiroshi Morisaki
  • Itsuo Nakatsuka
  • Saori Hashiguchi
  • Kei Miyakoshi
  • Mamoru Tanaka
  • Yasunori Yoshimura
  • Junzo Takeda
Original Article



Because the safety of intravenous fentanyl patient-controlled analgesia (iv-PCA) administered during labor remains unclear, we retrospectively examined the labor records from January 2005 to December 2007 in our institution, with a focus on both maternal and neonatal outcomes, as compared to no analgesia.


Parturients over 35 weeks of gestational age who received fentanyl iv-PCA (iv-PCA group) or no analgesia (control group) during labor were enrolled. The former group received iv-PCA through a pump programmed to give a loading dose of 0.05 mg fentanyl, followed by bolus injection of 0.02 mg fentanyl, with a lock-out interval of 5 min. This analgesia was initiated at the parturient’s request and was discontinued before the second stage of labor, to ensure neonatal safety. During labor, both maternal and fetal heart rates, maternal pulse oximeter oxygen saturation (SpO2), respiratory rate, and sedation and nausea scores were continuously monitored, and the neonatal outcomes including umbilical arterial pH, Apgar scores, and other parameters were recorded.


The data of 129 of the 143 parturients who received fentanyl iv-PCA were analyzed, while 697 parturients delivered without any analgesia during the 3-year study period. While iv-PCA prolonged the duration of labor and increased oxytocin use, no obvious maternal or neonatal complications of fentanyl use were recorded. Except for the significantly lower rate of emergency cesarean section in the iv-PCA group, both the maternal and neonatal outcomes were comparable between the groups.


As compared to no analgesia, fentanyl iv-PCA appears to be safe and clinically acceptable as analgesia during labor, particularly in nulliparous women.


Labor analgesia Fentanyl Intravenous patient-controlled analgesia 


  1. 1.
    Camann W. Pain relief during labor. N Engl J Med. 2005;352:718–20.PubMedCrossRefGoogle Scholar
  2. 2.
    Fun W, Lew E, Sia AT. Advances in neuraxial blocks for labor analgesia: new techniques, new systems. Minerva Anesthesiol. 2008;74:77–85.Google Scholar
  3. 3.
    Goetzl LM, ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical Management Guideline for Obstetrician-Gynecologists Number 36, July 2002. Obstetric analgesia and anesthesia. Obstet Gynecol. 2002;100:177–91.PubMedCrossRefGoogle Scholar
  4. 4.
    Hill D. The use of remifentanil in obstetrics. Anesthesiol Clin. 2008;26:169–82.PubMedCrossRefGoogle Scholar
  5. 5.
    Halpern SH, Muir H, Breen TW, Breen TW, Campbell DC, Barrett J, Liston R, Blanchard JW. A multicenter randomized controlled trial comparing patient-controlled epidural with intravenous analgesia for pain relief in labor. Anesth Analg. 2004;99:1532–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Reynolds F, Sharma SK, Seed PT. Analgesia in labour and fetal acid-base balance: a meta-analysis comparing epidural with systemic opioid analgesia. BJOG. 2002;109:1344–53.PubMedGoogle Scholar
  7. 7.
    Gouyon JB, Vintejoux A, Sagot P, Burguet A, Quantin C, Fredynus C, the Burgundy Perinatal Network. Neonatal outcome associated with singleton birth at 34–41 weeks of gestation. Int J Epidemiol. 2010;39:769–76.PubMedCrossRefGoogle Scholar
  8. 8.
    Nikkola EM, Ekblad UU, Kero PO, Alihanka JJ, Salonen MA. Intravenous fentanyl PCA during labour. Can J Anaesth. 1997;44:1248–55.PubMedCrossRefGoogle Scholar
  9. 9.
    Victory R, Penava D, Da Silva O, Natale R, Richardson B. Umbilical cord pH and base excess values in relation to adverse outcome events for infants delivering at term. Am J Obstet Gynecol. 2004;191:2021–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Sheiner E, Shoham-Vardi I, Hershkovitz R, Katz M, Mazor M. Infertility treatment is an independent risk factor for cesarean section among nulliparous women aged 40 and above. Am J Obstet Gynecol. 2001;185:888–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Lowe NK. The nature of labor pain. Am J Obstet Gynecol. 2002;186:S16–24.PubMedGoogle Scholar
  12. 12.
    Rosaeg OP, Kitts JB, Koren G, Byfold LJ. Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient. Can J Anaesth. 1992;39:277–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Scott JC, Ponganis KV, Stanski DR. EEG quantification of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology. 1985;62:234–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Olofsson C, Ekblom A, Ekman-Ordeberg G, Hjelm A, Irestedt L. Lack of analgesic effect of systemically administered morphine or pethidine on labour pain. Br J Obstet Gynecol. 1996;103:968–72.CrossRefGoogle Scholar
  15. 15.
    Reynolds F, Crowhurst JA. Opioids in labour—no analgesic effect. Lancet. 1997;349:4–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Nelson KE, Eisenach JC. Intravenous butorphanol, meperidine, and their combination relieve pain and distress in women in labor. Anesthesiology. 2005;102:1008–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Liu EH, Sia AT. Rates of cesarean section and instrumental vaginal delivery in nulliparous women after low concentration epidural infusion or opioid analgesia: systematic review. BMJ. 2004;328:1410–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Halpern SH, Leighton BL, Ohlsson A, Barrett JF, Rice A. Effect of epidural vs. parenteral opioid analgesia on the progress of labor: a meta analysis. JAMA. 1998;280:2105–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Rayburn WF, Smith CV, Parriott JE, Woods RE. Randomized comparison of meperidine and fentanyl during labor. Obstet Gynecol. 1989;74:604–6.PubMedGoogle Scholar
  20. 20.
    Jonsson M, Norden-Lindeberg S, Ostlund I, Hanson U. Acidemia at birth, related to obstetric characteristics and to oxytocin use, during the last two hours of labor. Acta Obstet Gynecol Scand. 2008;87:745–50.PubMedCrossRefGoogle Scholar
  21. 21.
    Morley-Forster PK, Weberpals J. Neonatal effect of patient-controlled analgesia using fentanyl in labor. Int J Obstet Anesth. 1998;7:103–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Wong CA, Scavone BM, Peaceman AM, McCarthy RJ, Sullivan JT, Diaz NT, Yaghmour E, Marcus RJL, Sherwani SS, Sproviero MT, Yilmaz M, Patel R, Robles C, Grouper S. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005;352:655–65.PubMedCrossRefGoogle Scholar
  23. 23.
    Sharma SK, McIntire DD, Wiley J, Leveno KJ. Labor analgesia and cesarean delivery: an individual patient meta-analysis of nulliparous women. Anesthesiology. 2004;100:142–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Evron S, Ezri T. Options for systemic labor analgesia. Curr Opin Anaesthesiol. 2007;20:181–5.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2011

Authors and Affiliations

  • Yuki Hosokawa
    • 1
  • Hiroshi Morisaki
    • 1
  • Itsuo Nakatsuka
    • 1
  • Saori Hashiguchi
    • 1
  • Kei Miyakoshi
    • 2
  • Mamoru Tanaka
    • 2
  • Yasunori Yoshimura
    • 2
  • Junzo Takeda
    • 1
  1. 1.Department of AnesthesiologyKeio University School of MedicineTokyoJapan
  2. 2.Department of Obstetrics and GynecologyKeio University School of MedicineTokyoJapan

Personalised recommendations